Literature DB >> 23042033

Cerebrospinal fluid miRNA profile in HIV-encephalitis.

Marco Pacifici1, Serena Delbue, Pasquale Ferrante, Duane Jeansonne, Ferdous Kadri, Steve Nelson, Cruz Velasco-Gonzalez, Jovanny Zabaleta, Francesca Peruzzi.   

Abstract

MicroRNAs are short non-coding RNAs that modulate gene expression by translational repression. Because of their high stability in intracellular as well as extracellular environments, miRNAs have recently emerged as important biomarkers in several human diseases. However, they have not been tested in the cerebrospinal fluid (CSF) of HIV-1 positive individuals. Here, we present results of a study aimed at determining the feasibility of detecting miRNAs in the CSF of HIV-infected individuals with and without encephalitis (HIVE). We also evaluated similarities and differences between CSF and brain tissue miRNAs in the same clinical setting. We utilized a high throughput approach of miRNA detection arrays and identified differentially expressed miRNAs in the frontal cortex of three cases each of HIV+, HIVE, and HIV- controls, and CSF of 10 HIV-positive and 10 HIV-negative individuals. For the CSF samples, the group of HIV+ individuals contained nine cases of HIV-associated neurological disorders (HAND) and, among those, four had HIVE. All the HIV-negative samples had non-viral acute disseminate encephalomyelitis. A total of 66 miRNAs were found differentially regulated in HIV+ compared to HIV- groups. The greatest difference in miRNA expression was observed when four cases of HIVE were compared to five non-HIVE cases, previously normalized with the HIV-negative group. After statistical analyses, 11 miRNAs were fund significantly up-regulated in HIVE. Although more clinical samples should be examined, this work represents the first report of CSF miRNAs in HIV-infection and offers the basis for future investigation.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23042033      PMCID: PMC3760673          DOI: 10.1002/jcp.24254

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  40 in total

1.  MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma.

Authors:  Jan-Lukas Robertus; Joost Kluiver; Callista Weggemans; Geert Harms; Rogier M Reijmers; Yolanthe Swart; Klaas Kok; Stefano Rosati; Ed Schuuring; Gustaaf van Imhoff; Steven T Pals; Philip Kluin; Anke van den Berg
Journal:  Br J Haematol       Date:  2010-03-15       Impact factor: 6.998

2.  Impact of normalization on miRNA microarray expression profiling.

Authors:  Sylvain Pradervand; Johann Weber; Jérôme Thomas; Manuel Bueno; Pratyaksha Wirapati; Karine Lefort; G Paolo Dotto; Keith Harshman
Journal:  RNA       Date:  2009-01-28       Impact factor: 4.942

Review 3.  Non-coding RNAs: regulators of disease.

Authors:  Ryan J Taft; Ken C Pang; Timothy R Mercer; Marcel Dinger; John S Mattick
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

Review 4.  Improved microRNA quantification in total RNA from clinical samples.

Authors:  Ditte Andreasen; Jacob U Fog; William Biggs; Jesper Salomon; Ina K Dahslveen; Adam Baker; Peter Mouritzen
Journal:  Methods       Date:  2010-04       Impact factor: 3.608

Review 5.  MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.

Authors:  William C S Cho
Journal:  Int J Biochem Cell Biol       Date:  2009-12-22       Impact factor: 5.085

Review 6.  Current understanding of HIV-associated neurocognitive disorders pathogenesis.

Authors:  Patrick Gannon; Muhammad Z Khan; Dennis L Kolson
Journal:  Curr Opin Neurol       Date:  2011-06       Impact factor: 5.710

7.  Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion lymphoma.

Authors:  Andrea J O'Hara; Wolfgang Vahrson; Dirk P Dittmer
Journal:  Blood       Date:  2007-12-13       Impact factor: 22.113

8.  MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival.

Authors:  Farshid Noorbakhsh; Rithwik Ramachandran; Nicola Barsby; Kristofor K Ellestad; Andrea LeBlanc; Peter Dickie; Glen Baker; Morley D Hollenberg; Eric A Cohen; Christopher Power
Journal:  FASEB J       Date:  2010-01-22       Impact factor: 5.191

9.  A novel mean-centering method for normalizing microRNA expression from high-throughput RT-qPCR data.

Authors:  Dennis Wylie; Jeffrey Shelton; Ashish Choudhary; Alex T Adai
Journal:  BMC Res Notes       Date:  2011-12-21

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more
  30 in total

1.  Anti-tumoral effects of miR-3189-3p in glioblastoma.

Authors:  Duane Jeansonne; Mariacristina DeLuca; Luis Marrero; Adam Lassak; Marco Pacifici; Dorota Wyczechowska; Anna Wilk; Krzysztof Reiss; Francesca Peruzzi
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

Review 2.  Noninvasive micromarkers.

Authors:  Janani Saikumar; Krithika Ramachandran; Vishal S Vaidya
Journal:  Clin Chem       Date:  2014-01-09       Impact factor: 8.327

Review 3.  Paving the path to HIV neurotherapy: Predicting SIV CNS disease.

Authors:  Sarah E Beck; Suzanne E Queen; Kenneth W Witwer; Kelly A Metcalf Pate; Lisa M Mangus; Lucio Gama; Robert J Adams; Janice E Clements; M Christine Zink; Joseph L Mankowski
Journal:  Eur J Pharmacol       Date:  2015-03-24       Impact factor: 4.432

4.  miRNA expression profiles in cerebrospinal fluid and blood of patients with acute ischemic stroke.

Authors:  Sofie Sølvsten Sørensen; Ann-Britt Nygaard; Ming-Yuan Nielsen; Kai Jensen; Thomas Christensen
Journal:  Transl Stroke Res       Date:  2014-08-17       Impact factor: 6.829

5.  Cerebrospinal fluid MicroRNA profiling using quantitative real time PCR.

Authors:  Marco Pacifici; Serena Delbue; Ferdous Kadri; Francesca Peruzzi
Journal:  J Vis Exp       Date:  2014-01-22       Impact factor: 1.355

Review 6.  HIV/neuroAIDS biomarkers.

Authors:  Pejman Rahimian; Johnny J He
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

7.  A miRNA Signature for Cognitive Deficits and Alcohol Use Disorder in Persons Living with HIV/AIDS.

Authors:  Dorota Wyczechowska; Hui-Yi Lin; Andrea LaPlante; Duane Jeansonne; Adam Lassak; Christopher H Parsons; Patricia E Molina; Francesca Peruzzi
Journal:  Front Mol Neurosci       Date:  2017-11-15       Impact factor: 5.639

8.  Epigenetic Promoter DNA Methylation of miR-124 Promotes HIV-1 Tat-Mediated Microglial Activation via MECP2-STAT3 Axis.

Authors:  Palsamy Periyasamy; Annadurai Thangaraj; Ming-Lei Guo; Guoku Hu; Shannon Callen; Shilpa Buch
Journal:  J Neurosci       Date:  2018-05-14       Impact factor: 6.167

9.  Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.

Authors:  Anna Wilk; Dorota Wyczechowska; Adriana Zapata; Matthew Dean; Jennifer Mullinax; Luis Marrero; Christopher Parsons; Francesca Peruzzi; Frank Culicchia; Augusto Ochoa; Maja Grabacka; Krzysztof Reiss
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

10.  Defining Plasma MicroRNAs Associated With Cognitive Impairment In HIV-Infected Patients.

Authors:  Ferdous Kadri; Andrea LaPlante; Mariacristina De Luca; Lisa Doyle; Cruz Velasco-Gonzalez; Jonathan R Patterson; Patricia E Molina; Steve Nelson; Arnold H Zea; Christopher H Parsons; Francesca Peruzzi
Journal:  J Cell Physiol       Date:  2016-04       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.